A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 194
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : LBD
Long Form : Lewy body disease
No. Year Title Co-occurring Abbreviation
2019 Clinical characteristics of elderly depressive patients with low metaiodobenzylguanidine uptake. HDRS, MIBG
2019 Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration. FTLD, MSA
2019 Effects of Lewy body disease and Alzheimer disease on brain atrophy and cognitive dysfunction. AD, ADCI, LBCI, MCI
2019 High-speed scanning of planar images showing 123I-MIBG uptake using a whole-body CZT camera: a phantom and clinical study. HMR, ICC, MIBG
2019 Mass synaptometry: High-dimensional multi parametric assay for single synapses. CytoF
2019 Neuropathological and genetic characteristics of a post-mortem series of cases with dementia with Lewy bodies clinically suspected of Creutzfeldt-Jakob's disease. AD, CJD, DLB
2018 Age- and disease-dependent increase of the mitophagy marker phospho-ubiquitin in normal aging and Lewy body disease. mitoQC, PD, Ub
2018 Aging and cerebrovascular lesions in pure and in mixed neurodegenerative and vascular dementia brains: aneuropathological study. AD, CAA, CoMBs, CoMIs, FTLD, WMCs
2018 Augmented frontal cortex diacylglycerol levels in Parkinson's disease and Lewy Body Disease. AD, DAG, MCI, PD
10  2018 Development of an 123I-metaiodobenzylguanidine Myocardial Three-Dimensional Quantification Method for the Diagnosis of Lewy Body Disease. 123I-MIBG, DLB, PD, SPECT
11  2018 Differential diagnosis of parkinsonian syndromes using dopamine transporter and perfusion SPECT. APS, AUC, CBS, DAT, LOOCV, MSA, PD, PSP, ROC, TDA
12  2018 Early diagnosis of Lewy body disease in patients with late-onset psychiatric disorders using clinical history of rapid eye movement sleep behavior disorder and [123 I]-metaiodobenzylguanidine cardiac scintigraphy. DAT, RBD, RWA
13  2018 Forgetting Rate on the Recency Portion of a Word List Differentiates Mild to Moderate Alzheimer's Disease from Other Forms of Dementi. AD, fv-FTD, NC, SIVD
14  2018 INDEL Length and Haplotypes in the beta-Synuclein Gene: A Key to Differentiate Dementia with Lewy Bodies? AD, DLB, InDel, PD
15  2018 Lewy Body Disease: Clinical and Pathological "Overlap Syndrome" Between Synucleinopathies (Parkinson Disease) and Tauopathies (Alzheimer Disease). AD, PD, PDD
16  2018 Lewy Body Pathology and Chronic Traumatic Encephalopathy Associated With Contact Sports. AD, CTE
17  2018 Lysosomes, autophagosomes and Alzheimer pathology in dementia with Lewy body disease. CG, CTSD, LC3A, SN
18  2018 Methylation changes and aberrant expression of FGFR3 in Lewy body disease neurons. ---
19  2018 Prion-Like Seeding of Misfolded alpha-Synuclein in the Brains of Dementia with Lewy Body Patients in RT-QUIC. alpha-Syn, DLB, r-alphaSyn, RT-QuIC, Ser129
20  2018 Risk factors of hippocampal sclerosis in the oldest old: The 90+ Study. CI, HS, OR
21  2018 Tau Positron Emission Tomography Imaging in Degenerative Parkinsonisms. AD, PET
22  2018 Voxel-wise deviations from healthy aging for the detection of region-specific atrophy. AD, CSF, FTD, GM, HC
23  2018 What Promises the CJD Diagnosis in a Case of Rapidly Progressive Dementia? CJD, CSF, EEG, MRI, PET, RT-QuIC
24  2018 [I Am Seeing a Human!: The Perception of an External Visual Stimulus Where None Exists]. VH
25  2017 123I-FP-CIT SPECT findings and its clinical relevance in prodromal dementia with Lewy bodies. AD, CLIN-DLB, DLB, PRD-DLB, RBD, SBR
26  2017 Alzheimer's disease neuropathologic change, Lewy body disease, and vascular brain injury in clinic- and community-based samples. ADNC, VBI
27  2017 Comorbidities. AD, HPtau
28  2017 Delirium prior to dementia as a clinical phenotype of Lewy body disease: an autopsied case report. DLB
29  2017 Duration and Pathologic Correlates of Lewy Body Disease. DLB, NFT
30  2017 Interactions of pathological proteins in neurodegenerative diseases. AD, ALS, FTD, PD
31  2017 Mixed neuropathologies and associations with domain-specific cognitive decline. ADNC, VBI
32  2017 Mixed neuropathologies and estimated rates of clinical progression in a large autopsy sample. ADNP, VBI
33  2017 Parkinson's disease susceptibility variants and severity of Lewy body pathology. Cg, GWAS, IP, MF, PD, PH, ST
34  2017 Performance of a Condensed Protocol That Reduces Effort and Cost of NIA-AA Guidelines for Neuropathologic Assessment of Alzheimer Disease. AD, CAA, HS, MVLs
35  2017 Possible effectiveness of low-dose pregabalin in a patient suffering from Lewy body disease and chronic pruritus. ---
36  2017 Quantitative neuropathology: an update on automated methodologies and implications for large scale cohorts. AD, HP-T, TMA
37  2017 Rapid eye movement sleep without atonia may help diagnose Lewy body disease in middle-aged and older patients with somatic symptom disorder. DLB, PD, REM
38  2017 Structural and Functional Neuroimaging of Visual Hallucinations in Lewy Body Disease: A Systematic Literature Review. DLB, PD, VH
39  2017 Update on Current Care guideline: Memory Disorders. AD
40  2017 Uptake Index of 123I-metaiodobenzylguanidine Myocardial Scintigraphy for Diagnosing Lewy Body Disease. 123I-MIBG, AUC, DLB, NPV, PA, PD, PPV
41  2016 123I-MIBG myocardial scintigraphy for the evaluation of Lewy body disease: are delayed images essential? Is visual assessment useful? 123I-MIBG, NPV, PPV
42  2016 alpha-Synuclein pathology in the cranial and spinal nerves in Lewy body disease. MSA
43  2016 Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort. Abeta42, AD, CSF, DLB, p-tau, PD, PDD, t-tau
44  2016 Cortical Lewy bodies and Abeta burden are associated with prevalence and timing of dementia in Lewy body diseases. CLB, DLB, LB, NT, OR
45  2016 Hippocampal Sclerosis but Not Normal Aging or Alzheimer Disease Is Associated With TDP-43 Pathology in the Basal Forebrain of Aged Persons. AD, HS-Aging, TAR
46  2016 MMSE and MoCA in Parkinson's disease and dementia with Lewy bodies: a multicenter 1-year follow-up study. MMSE, MoCA, PD
47  2016 Neuropathologic differences by race from the National Alzheimer's Coordinating Center. AAs, APOE, CVD
48  2015 A Review of the Role of Anticholinergic Activity in Lewy Body Disease and Delirium. AA, ACh, AD
49  2015 C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian population. ALS, CBD, FTD, MSA, PD, PSP
50  2015 Comparison of the diagnostic performance of H/M ratio between early and delayed phases for Lewy body disease. MIBG
51  2015 Diagnosis of dementias by high-field 1H MRS of cerebrospinal fluid. AD, CSF, FTD, MRS
52  2015 DNAJC13 p.Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patients. PD
53  2015 False memories in Lewy-body disease. DRM, gist memory
54  2015 Genetic markers in biological fluids for aging-related major neurocognitive disorder. AD, FTLD, NCD, VaD
55  2015 Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A. FTLD-TDP, HpScl, NFT
56  2015 Incidence and extent of TDP-43 accumulation in aging human brain. AD, AGD, ALS, DNs, TDP-43
57  2015 Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders. PD
58  2015 Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes. AD, cAD, DLB, HP-tau, PDD
59  2015 Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies. AD, FTLD, OB, PSP
60  2015 p62 Deficiency Enhances alpha-Synuclein Pathology in Mice. NBr1, Tg mice
61  2015 Prodromal dementia with Lewy bodies. AD, DLB, PD, RBD
62  2015 Progressive Supranuclear Palsy Syndrome and Semantic Dementia in Neuropathologically Proven Lewy Body Disease: A Report of Two Cases. ---
63  2015 Pure psychiatric presentation of the Lewy body disease is depression--an analysis of 60 cases verified with myocardial meta-iodobenzylguanidine study. DLB, MIBG, MMSE, PD, PDD, PPP, UPDRS
64  2015 Quantitative correlation between cardiac MIBG uptake and remaining axons in the cardiac sympathetic nerve in Lewy body disease. MIBG, NF, TH
65  2015 Role for the microtubule-associated protein tau variant p.A152T in risk of alpha-synucleinopathies. CI, DLB, MAF, MSA, OR, PD
66  2015 Trehalose intake induces chaperone molecules along with autophagy in a mouse model of Lewy body disease. ---
67  2014 Argyrophilic grain disease as a neurodegenerative substrate in late-onset schizophrenia and delusional disorders. AD, AGD, CBD, LOSD
68  2014 Flow cytometry analysis of synaptosomes from post-mortem human brain reveals changes specific to Lewy body and Alzheimer's disease. AD, DA, DAT, DL, DOPAC, DT, PT, VM
69  2014 Genetics in degenerative dementia: current status and applicability. AD, FTD
70  2014 Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias. AD, APOE, CAA, GALNT7, HS, VBI
71  2014 Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques? DLB, MIBG, PD, SPECT
72  2014 Lewy body disease and dementia with Lewy bodies. AD, DLB, DLBD, PD, PDD
73  2014 Lyme neuroborreliosis and dementia. AD, AI, CSF
74  2014 N-methyl-d-aspartate glutamate receptor (NMDA-R) antibodies in mild cognitive impairment and dementias. Abs, AD, FTD, MCI, NMDA-R, SIVD
75  2014 Post-mortem 7.0-tesla magnetic resonance study of cortical microinfarcts in neurodegenerative diseases and vascular dementia with neuropathological correlates. AD, CMIs, MRI, VaD
76  2014 Update on SPECT and PET in parkinsonism - part 2: biomarker imaging of cognitive impairment in Lewy-body diseases. PD, PDD, PET, SPECT
77  2014 [Multiple system atrophy and autophagy]. Atg, MSA
78  2013 123I-iodobenzamide SPECT is not an independent predictor of dopaminergic responsiveness in patients with suspected atypical parkinsonian syndromes. APS, D2R
79  2013 APOE epsilon4 increases risk for dementia in pure synucleinopathies. AD, APOE, NCs, PDD, pDLB
80  2013 Changes in properties of serine 129 phosphorylated alpha-synuclein with progression of Lewy-type histopathology in human brains. DLB, PD
81  2013 Clinical significance of lung iodine-123 metaiodobenzylguanidine uptake assessment in Parkinson's and heart diseases. ePAP, HD, LV
82  2013 Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. AD, MSA, NBAI-1, PSG, PSP, REM
83  2013 CSF alpha-synuclein improves diagnostic and prognostic performance of CSF tau and Abeta in Alzheimer's disease. Abeta1-42, AD, ADNI, alpha-syn-p-tau181-Mis, CSF, DLB, MCI, p-tau181, PD, PPMI, t-tau
84  2013 Effects of antiparkinsonian agents on beta-amyloid and alpha-synuclein oligomer formation in vitro. AD, alphaS, PICUP
85  2013 Fortress brain. AD
86  2013 Neural correlates of cognitive dysfunction in Lewy body diseases and tauopathies: combined assessment with FDG-PET and the CERAD test battery. ---
87  2013 Neuropathologic analysis of Lewy-related alpha-synucleinopathy in olfactory mucosa. ---
88  2013 Neuropathologic correlates of cognition in a population-based sample. AD, VBI
89  2013 Pathology and temporal onset of visual hallucinations, misperceptions and family misidentification distinguishes dementia with Lewy bodies from Alzheimer's disease. AD, AD-ALB
90  2013 Relation of neuropathology with cognitive decline among older persons without dementia. AD, CVD
91  2012 Adult Changes in Thought study: dementia is an individually varying convergent syndrome with prevalent clinically silent diseases that may be modified by some commonly used therapeutics. ACT, AD, mVBI
92  2012 GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. AD, AD, CI, LBD-AD, OR, PD, pDLB
93  2012 Glucocerebrosidase mutations alter the endoplasmic reticulum and lysosomes in Lewy body disease. ER, GCase, UPR
94  2012 Lewy body-related alpha-synucleinopathy in the spinal cord of cases with incidental Lewy body disease. ILBD, palphaSyn, PD
95  2012 Mild cognitive impairment associated with underlying Alzheimer's disease versus Lewy body disease. AD, DAT, FDG-PET, MCI, MRI
96  2012 Neuropathological analysis of brainstem cholinergic and catecholaminergic nuclei in relation to rapid eye movement (REM) sleep behaviour disorder. AD, LC, PPN/LDT, RBD, REM
97  2012 [Cerebrospinal fluid and plasma biomarkers for dementia with lewy bodies]. CSF, DLB, PD
98  2012 [⁸F]FDG-PET is superior to [I]IBZM-SPECT for the differential diagnosis of parkinsonism. APS, CBD, D2R, IBZM, MSA, PD, PSP
99  2011 Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND. AD, FTLD
100  2011 Comparison of parameters of (123)I-metaiodobenzylguanidine scintigraphy for differential diagnosis in patients with parkinsonism: correlation with clinical features. HY, MIBG, PD, PS, WR